1 Department of Clinical Neuroscience and Centrum for Molecular Medicine at Karolinska, Institutet, Stockholm, Sweden. Electronic address: anna.glaser@ki.se.
2 MS-Register of the German MS-Society, MS Forschungs- und Projektentwicklungs-gGmbH, Hannover, Germany.
3 University Medical Center Göttingen, Department of Medical Informatics, Göttingen, Germany.
4 Neurological Rehabilitation Center Quellenhof, Bad Wildbad, Germany.
5 Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.
6 Italian Multiple Sclerosis Foundation, Via Operai 40, Genoa 16149, Italy; MS International Federation, London, UK.
7 MS International Federation, London, UK; Scientific Research Area, Italian MS Society, Genoa, Italy.
8 Department of Biomedical and Surgical Sciences, University of Ferrara, Italy; S. Anna University Hospital, Via Aldo Moro 8 - 1C3, 44124 Ferrara, (FE), Italy.
9 Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, F-69677 Bron, France; Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR5292, F-69003, Lyon, France; Université de Lyon, Université Claude Bernard Lyon 1, F-69000, Lyon, France; Eugène Devic EDMUS Foundation against Multiple Sclerosis, state-approved foundation, F-69677 Bron, France.
10 Italian Multiple Sclerosis Foundation, Via Operai 40, Genoa 16149, Italy; MS International Federation, London, UK; Department of Life Sciences, University of Siena, Italy.
11 Department of Neurology, Specialist Hospital, Końskie, Poland; The Faculty of Medicine and Health Science, Institute of Physiotherapy, Jan Kochanowski University, Kielce, Poland.
12 Central Clinical School, Alfred Centre, Monash University, 99 Commercial Rd, Melbourne, VIC 3004, Australia.
13 Clinic of Neurology, CCS, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
14 Department of Neurology, St. Josef-Hospital Bochum, Ruhr University Bochum, Bochum, Germany.
15 Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Italy.
16 The Greek Multiple Sclerosis Society, Thessaloniki, Greece.
17 Neurology, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Switzerland.
18 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
19 The Danish Multiple Sclerosis Registry, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark.
20 Association of multiple sclerosis societies of Croatia, Trnsko 34, p.p.74, Zagreb 10020, Croatia.
21 Swansea University Medical School, SWANSEA SA2 8PP, United Kingdom.
22 Department of Clinical Medicine, University of Bergen, Norway; The Norwegian MS-Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
23 The Greek Multiple Sclerosis Society, Thessaloniki, Greece; Aristotle University of Thessaloniki, Greece.
24 Aristotle University of Thessaloniki, Greece.
25 Preventive Medicine and Epidemiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Neurology / Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
26 Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Serbia.
27 Department of Neurology / Neuroimmunology, Multiple Sclerosis Centre of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
28 President of the Belgian Study Group for Multiple Sclerosis, Belgium.
29 Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland.
30 Department of Neurology, MS Center Dresden, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Germany.
31 Department of Clinical Neuroscience and Centrum for Molecular Medicine at Karolinska, Institutet, Stockholm, Sweden.
32 European Multiple Sclerosis Platform (EMSP), Schaerbeek, Belgium.